While pressure to grow will drive more large drug makers to pursue mergers and acquisitions, diminished resources and competition from biotech and specialty pharmaceutical companies will challenge their ability to do so, according to a new report.
The head of Lupin Pharmaceuticals has received an award from accounting firm Ernst & Young.
Walgreens on Tuesday evening elected Jan Babiak, a retired managing partner for Ernst & Young, to its board of directors.
Chirag Patel and Chintu Patel, who respectively are the president and CEO of Amneal Pharmaceuticals, recently received the Ernst & Young Entrepreneur of the Year award.
Diplomat Specialty Pharmacy on Friday announced Diplomat president and CEO Phil Hagerman was named Ernst...